Slow Recovery Likely for Business Travel
Firms are a long way from returning to the days of big spending.

Business travel faces a long comeback. Although the industry will grow this year and on through 2013, the number of trips in 2013 will be only 485 million compared with nearly 567 million in 2000.
Videoconferencing is one reason. It’s now cheap enough and of sufficient quality to replace many face-to-face meetings, says Suzanne Cook, senior vice president of the U.S. Travel Association. Still, “not all travel can be replaced by sitting in front of a screen,” says Cook. Corporate travel policies that were tightened during the recession will be eased but will continue to require road warriors to justify each and every trip.
That will restrain any recuperation of hotels and restaurants. A modest uptick of 3% in revenue per hotel room is likely this year, followed by a 6.5% increase in 2011. It will take four to five years before the industry will fully recover from the downturn, analysts say.

Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Luxury hotels, which were particularly hard hit by the recession, will also make gains this year. Revenue per hotel room will be up about 5% after dropping 23% last year as companies, fearing bad publicity from having employees attend events in luxury surroundings, canceled trips and group meetings at those properties.
Full-service restaurants will see a slight increase of 1.2% this year after a 4% drop last year. But fast-food outlets and nonalcoholic beverage bars (think Starbucks) are sitting pretty. Fast-food establishments grew throughout the recession, while this year the Seattle coffee giant will enjoy a smart revenue rebound after a sales decline in 2009.
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.

-
Four Surprising Signs You’ll Never Retire (and How to Fix Them)
Gearing up to retire? If any of these four signs ring true, you may want to make some changes before you do.
-
Stocks Rise After Trump-Powell Fed Tour: Stock Market Today
Nvidia hit a new all-time high intraday, but another renowned semiconductor name and some less iconic stocks were bigger movers Friday.
-
AI-Powered Smart Glasses Set to Make a Bigger Splash
The Kiplinger Letter Meta leads the way with its sleek, fashionable smart glasses, but Apple reportedly plans to join the fray by late 2026. Improved AI will lure more customers.
-
Breaking China's Stranglehold on Rare Earth Elements
The Letter China is using its near-monopoly on critical minerals to win trade concessions. Can the U.S. find alternate supplies?
-
Things that Surprise Business Owners When It’s Time to Sell
The Kiplinger Letter When it’s time to retire and enjoy the fruits of growing their business, owners are often surprised by how tough it is to give up their baby!
-
What New Tariffs Mean for Car Shoppers
The Kiplinger Letter Car deals are growing scarcer. Meanwhile, tax credits for EVs are on the way out, but tax breaks for car loans are coming.
-
AI’s Rapid Rise Sparks New Cyber Threats
The Kiplinger Letter Cybersecurity professionals are racing to ward off AI threats while also using AI tools to shore up defenses.
-
Blue Collar Workers Add AI to Their Toolboxes
The Kiplinger Letter AI can’t fix a leak or install lighting, but more and more tradespeople are adopting artificial intelligence for back-office work and other tasks.
-
The New AI Agents Will Tackle Your To-Do List
The Kiplinger Letter Autonomous AI agents “see” your computer screen, then complete a task, from buying a concert ticket to organizing email. This opens up a world of possibilities.
-
AI’s Medical Revolution
The Kiplinger Letter Medicine is a field ripe for finding both exciting and practical uses for AI. The tech is already being used by doctors and researchers.